ArticleScientific reports2026
Sexual dysfunction among Egyptian men with chronic hepatitis C in the post elimination era prevalence and associated factors.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite Egypt’s landmark achievement in controlling hepatitis C virus (HCV) and receiving WHO validation on the path to elimination, long-term sequelae among men previously affected by chronic HCV remain under-recognized. Sexual dysfunction is an important yet often overlooked component of survivorship and quality of life in chronic liver disease care. To estimate the prevalence and identify factors independently associated with sexual dysfunction among Egyptian men with chronic HCV, informing post-elimination care strategies. A cross-sectional analysis was conducted on 1,500 adult males attending National Committee for Control of Viral Hepatitis (NCCVH) units across six geographically diverse Egyptian governorates. Sexual health was assessed using the Brief Sexual Symptom Checklist for Men and the International Index of Erectile Function (IIEF-5). Logistic regression was applied to identify factors independently associated with sexual dysfunction. The overall prevalence of at least one form of sexual dysfunction was 72.8%. Erectile dysfunction was most common (59.3%), followed by desire dysfunction (47.5%) and premature ejaculation (32.1%), orgasmic dysfunction (27.8%), and dyspareunia (12.6%). The strongest independent associations clustered around markers of advanced disease severity and complications, particularly hepatocellular carcinoma (DD AOR: 12.39; 95% CI: 4.64–33.09; PE AOR: 8.99; 95% CI: 2.06–39.25) and age ≥ 50 years (DD AOR: 5.00; 95% CI: 3.65–6.85; PE AOR: 7.58; 95% CI: 4.17–13.76). Diabetes mellitus was also strongly associated with erectile dysfunction (AOR: 3.89; 95% CI: 2.07–7.30) and premature ejaculation (AOR: 3.33; 95% CI: 1.72–6.44). Sexual dysfunction is a common, under-recognized sequela among Egyptian men with chronic HCV in the post-elimination era. The strongest independent associations were observed with advanced liver disease/complications and metabolic comorbidity, supporting integration of routine sexual health assessment and counseling into post-HCV follow-up. Survivorship-oriented care is particularly important for patients with advanced liver disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.